On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Recent Updates
- NYSDOL Releases Guidance on Trapped at Work Act
- Governor Hochul Re-Elected: How New York Employers Should Prepare as 2026 Ends
- Allegheny County Adopts Employer-Funded Paid Parental Leave Law
- When the AI Agent Goes Off-Script: The First Incident Playbook for Frontier AI
- Revised New York City Fair Chance Rules Take Effect October 30